U.S. federal trademark · Serial No. 75144476
pharmaceutical preparation, namely, a novel formulation of paclitaxel for the treatment of breast cancer, ovarian cancer, lung cancer, prostate cancer, head and neck cancer, brain tumors, and for the prevention of restinosis post angioplasty
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.